Supplements for Neurodegenerative Pathology

What the Research Shows

Current research into supplements for neurodegenerative pathology shows a wide gap between laboratory potential and clinical success. Most substances that show promise in animal models fail to demonstrate significant cognitive or structural benefits in human trials. While some nutrients are essential for brain health, there is limited evidence that high-dose supplementation can reverse or stop the progression of established neurodegenerative diseases. Nicotinamide Riboside currently has moderate evidence suggesting it may support cellular energy and mitochondrial function, though long-term clinical outcomes remain under study. Other common supplements, such as Omega-3 fatty acids and antioxidants, generally show weak to insufficient evidence for treating active pathology, often providing only modest preventative benefits in healthy populations. Many studies are limited by small sample sizes, short durations, and conflicting results across different patient groups. Consequently, the evidence for most supplements in this area remains inconclusive.

AI-generated overview based on research evidence. Not medical advice.

This page is generated from AI-analyzed evidence summaries. Evidence strength ratings are based on the quality and quantity of available research, not guaranteed effectiveness. Always consult a healthcare provider before using supplements for any health condition.

See our Editorial Policy for methodology and Medical Disclaimer.